Sep 12, 2022 Press Releases
PDF Version AT-01 shows increased LV uptake and LV amyloid activity in all cardiac ATTR and AL subjects, but in none of the controls (100% accuracy) AT-01 demonstrates significantly higher left ventricular uptake in ATTR-CMP participants than florbetapir SAN...
Sep 8, 2022 Press Releases
PDF Version AT-01 is a first-in-class pan-amyloid imaging agent capable of detecting diverse types of systemic amyloidosis in multiple organs Sensitivity in those with previously diagnosed cardiac disease was 100% in ATTR and 93% in AL Organ-specific changes in...
Sep 7, 2022 Press Releases
PDF Version AT-04 demonstrates potent binding and promotes phagocytosis in ATTR and AL amyloidosis AT-04 binds potently to Aβ, tau, and α-synuclein, common amyloid pathologies in CNS disorders such as Alzheimer’s SAN FRANCISCO, Calif. – September 7, 2022 –...
Sep 7, 2022 Posters & Publications
AUTHORS: James S. Foster1, Spencer Guthrie2, Michael L. Klein2, Gregory Bell2, Suganya Selvarajah2, Angela D. Williams1, Manasi Balachandran1, Joseph W. Jackson1, Alan Stuckey1, Emily Martin1, Sallie Macy1, D. Craig Wooliver1, R. Eric Heidel1, Stephen J. Kennel1,...
Sep 7, 2022 Posters & Publications
AUTHORS: Christophe Sirac1, Roussine Codo1, Arnaud Jaccard1, Sébastien Bender1, Gemma Martinez Rivas1, Frank Bridoux2, Michael Klein3, Gregory Bell3, Spencer Guthrie3, Suganya Selvarajah3, Stephen J. Kennel4, Angela D. Williams4, James S. Foster4, Jonathan S. Wall4 1...
